2015
DOI: 10.2967/jnumed.114.148023
|View full text |Cite
|
Sign up to set email alerts
|

Risk Stratification of Metastatic Neck Nodes by CT and PET in Patients with Head and Neck Cancer Receiving Definitive Radiotherapy

Abstract: The aim of this study was to investigate the prognostic impact of CT and 18 F-FDG PET/CT on the outcome of metastatic neck node (MNN) in patients with head and neck cancer receiving definitive radiotherapy or chemoradiotherapy. Methods: This patient-based study included 91 patients diagnosed with pharyngeal cancers with MNN (N1, 15; N2, 70; N3, 6). All had pretreatment CT and PET/CT before definitive chemoradiotherapy/radiotherapy. Parameters of MNNs for each patient, including maximal diameter, nodal volume, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
18
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(18 citation statements)
references
References 25 publications
0
18
0
Order By: Relevance
“…In addition, Tang et al revealed, in 2014, that necrosis of metastatic retropharyngeal lymph nodes was a significant independent prognostic factor for DMFS and locoregional relapse-free survival in NPC patients treated with IMRT 29. Lin et al recently reported that radiological lymph node necrosis on CT was an independent risk factor for OS, DFS, and nodal relapse-free survival in patients with HNC treated with IMRT with or without chemotherapy 17, while Lan et al concluded that CNN on MRI was a significant, independent, negative prognostic factor for OS, RRFS, DMFS, and DFS in NPC patients treated with 2D radiotherapy, three-dimensional (3D) radiotherapy, or IMRT 20. However, the patients in most of these studies were treated with 2D or 3D radiotherapy.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, Tang et al revealed, in 2014, that necrosis of metastatic retropharyngeal lymph nodes was a significant independent prognostic factor for DMFS and locoregional relapse-free survival in NPC patients treated with IMRT 29. Lin et al recently reported that radiological lymph node necrosis on CT was an independent risk factor for OS, DFS, and nodal relapse-free survival in patients with HNC treated with IMRT with or without chemotherapy 17, while Lan et al concluded that CNN on MRI was a significant, independent, negative prognostic factor for OS, RRFS, DMFS, and DFS in NPC patients treated with 2D radiotherapy, three-dimensional (3D) radiotherapy, or IMRT 20. However, the patients in most of these studies were treated with 2D or 3D radiotherapy.…”
Section: Discussionmentioning
confidence: 99%
“…Several previous studies have shown a correlation between the presence of hypodense lymph nodes, which indicate CNN, or CNN on CT and the likelihood of regional failure after radiotherapy and/or chemotherapy in patients with head and neck cancer (HNC), but not NPC 17-19.…”
Section: Introductionmentioning
confidence: 99%
“…The choice of the threshold for either method may affect the absolute value of the MTV. Six studies compared the predictive value of MTV and/or TLG computed with different thresholds (Cheng et al, 2015;Kao et al, 2012;Lin et al, 2015;Schinagl et al, 2011;Yabuki et al, 2015). In the study by (Schinagl et al, 2011), 4 thresholds (2.5, 40%, 50% and adaptive threshold based on liver uptake) were compared for 77 patients treated with RT ± CT. MTV 40% was the strongest predictor of DFS and OS.…”
Section: Suvmax and Metabolic Tumor Volumementioning
confidence: 99%
“…Their results showed higher sensitivity respectively for PET/HRCT, PET/CT and HRCT in recurrence detection of their heterogenous patient population [14]. In addition, a few studies comparing the accuracy of these two modalities without accounting for the same day PET/CT and CECT scans have been reported [2427]. In a prospective trial, Moeller and his colleagues claimed that PET/CT was not superior to CECT scan in therapy assessment of patients with OPSCC.…”
Section: Discussionmentioning
confidence: 99%